Terms: = Liver cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
19 results:
1. Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.
Zhao Q; Li B; Xu Y; Wang S; Zou B; Yu J; Wang L
Cancer Med; 2021 Sep; 10(18):6291-6303. PubMed ID: 34390218
[TBL] [Abstract] [Full Text] [Related]
2. Synergistic effect of toosendanin and regorafenib against cell proliferation and migration by regulating WWOX signaling pathway in hepatocellular carcinoma.
Yang T; Huo J; Xu R; Zhang Y
Phytother Res; 2021 Aug; 35(8):4567-4578. PubMed ID: 34058790
[TBL] [Abstract] [Full Text] [Related]
3. The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification.
Rehm J; Patra J; Brennan A; Buckley C; Greenfield TK; Kerr WC; Manthey J; Purshouse RC; Rovira P; Shuper PA; Shield KD
Drug Alcohol Rev; 2021 Nov; 40(7):1377-1386. PubMed ID: 33783063
[TBL] [Abstract] [Full Text] [Related]
4. Hospital volume and mortality in liver resections for colorectal metastasis using population-based administrative data.
Hunger R; Mantke A; Herrmann C; Grimm AL; Ludwig J; Mantke R
J Hepatobiliary Pancreat Sci; 2019 Dec; 26(12):548-556. PubMed ID: 31562836
[TBL] [Abstract] [Full Text] [Related]
5. The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas.
Wang X; Chen D; Chen B
Acad Radiol; 2020 Dec; 27(12):1720-1726. PubMed ID: 29941397
[TBL] [Abstract] [Full Text] [Related]
6. Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30).
Yang Q; Guo X; Yang L
Med Sci Monit; 2018 Apr; 24():2225-2234. PubMed ID: 29654226
[TBL] [Abstract] [Full Text] [Related]
7. Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program.
Ecker BL; Simmons KD; Zaheer S; Poe SL; Bartlett EK; Drebin JA; Fraker DL; Kelz RR; Roses RE; Karakousis GC
JAMA Surg; 2016 Jun; 151(6):518-25. PubMed ID: 26763765
[TBL] [Abstract] [Full Text] [Related]
8. Preoperative serum methylation signature as prognostic tool after curative hepatectomy in patients with hepatocellular carcinoma.
Kanekiyo S; Iizuka N; Tsunedomi R; Tokumitsu Y; Hashimoto N; Tokuhisa Y; Maeda Y; Iida M; Sakamoto K; Tamesa T; Fujita Y; Yoshino S; Hazama S; Hamamoto Y; Oka M
Anticancer Res; 2015 Feb; 35(2):997-1007. PubMed ID: 25667487
[TBL] [Abstract] [Full Text] [Related]
9. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.
Villanueva A; Portela A; Sayols S; Battiston C; Hoshida Y; Méndez-González J; Imbeaud S; Letouzé E; Hernandez-Gea V; Cornella H; Pinyol R; Solé M; Fuster J; Zucman-Rossi J; Mazzaferro V; Esteller M; Llovet JM;
Hepatology; 2015 Jun; 61(6):1945-56. PubMed ID: 25645722
[TBL] [Abstract] [Full Text] [Related]
10. RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC).
Ezzeldin M; Borrego-Diaz E; Taha M; Esfandyari T; Wise AL; Peng W; Rouyanian A; Asvadi Kermani A; Soleimani M; Patrad E; Lialyte K; Wang K; Williamson S; Abdulkarim B; Olyaee M; Farassati F
Mol Oncol; 2014 Jul; 8(5):1043-53. PubMed ID: 24785097
[TBL] [Abstract] [Full Text] [Related]
11. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
[TBL] [Abstract] [Full Text] [Related]
12. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.
Gus-Brautbar Y; Johnson D; Zhang L; Sun H; Wang P; Zhang S; Zhang L; Chen YH
Mol Cell; 2012 Mar; 45(5):610-8. PubMed ID: 22326055
[TBL] [Abstract] [Full Text] [Related]
13. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.
Chan KC; Lai PB; Mok TS; Chan HL; Ding C; Yeung SW; Lo YM
Clin Chem; 2008 Sep; 54(9):1528-36. PubMed ID: 18653827
[TBL] [Abstract] [Full Text] [Related]
14. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract] [Full Text] [Related]
15. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract] [Full Text] [Related]
16. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome.
Nagino M; Kamiya J; Arai T; Nishio H; Ebata T; Nimura Y
Surgery; 2005 Feb; 137(2):148-55. PubMed ID: 15674194
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.
Johnson SA; Mandavia N; Wang HD; Johnson DL
Mol Cell Biol; 2000 Jul; 20(14):5000-9. PubMed ID: 10866657
[TBL] [Abstract] [Full Text] [Related]
18. The human RGL (ralgds-like) gene: cloning, expression analysis and genomic organization.
Sood R; Makalowska I; Carpten JD; Robbins CM; Stephan DA; Connors TD; Morgenbesser SD; Su K; Pinkett HW; Graham CL; Quesenberry MI; Baxevanis AD; Klinger KW; Trent JM; Bonner TI
Biochim Biophys Acta; 2000 Apr; 1491(1-3):285-8. PubMed ID: 10760592
[TBL] [Abstract] [Full Text] [Related]
19. Cytokeratin filament expression during in vitro teratocarcinoma cell differentiation as detected by a monoclonal antibody.
Ramaekers F; Schaap H; Mulder M; Huysmans A; Vooijs P
Cell Biol Int Rep; 1984 Jun; 8(6):507-18. PubMed ID: 6204783
[TBL] [Abstract] [Full Text] [Related]
